Published in Nat Mater on February 15, 2004
Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol (2007) 6.85
Materials engineering for immunomodulation. Nature (2009) 2.18
Near-infrared-emissive polymersomes: self-assembled soft matter for in vivo optical imaging. Proc Natl Acad Sci U S A (2005) 2.10
Self-assembling materials for therapeutic delivery. Acta Biomater (2008) 1.51
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci U S A (2011) 1.39
Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide. J Am Chem Soc (2012) 1.23
Multi-stimuli sensitive amphiphilic block copolymer assemblies. J Am Chem Soc (2009) 1.21
Polymersome carriers: from self-assembly to siRNA and protein therapeutics. Eur J Pharm Biopharm (2008) 1.21
Engineered polymers for advanced drug delivery. Eur J Pharm Biopharm (2008) 1.17
Cross-linking and degradation of step-growth hydrogels formed by thiol-ene photoclick chemistry. Biomacromolecules (2012) 1.15
Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles. Pharmacol Rev (2012) 1.15
Nano-enabled synthetic biology. Mol Syst Biol (2007) 1.15
Polymersomes: a new multi-functional tool for cancer diagnosis and therapy. Methods (2008) 1.09
Stimuli-responsive copolymer solution and surface assemblies for biomedical applications. Chem Soc Rev (2013) 1.06
Inflammation responsive logic gate nanoparticles for the delivery of proteins. Bioconjug Chem (2011) 1.04
Polymersome delivery of siRNA and antisense oligonucleotides. J Control Release (2008) 1.04
Bursting of sensitive polymersomes induced by curling. Proc Natl Acad Sci U S A (2009) 1.00
Enzyme-directed assembly of a nanoparticle probe in tumor tissue. Adv Mater (2013) 0.95
Biological stimuli and biomolecules in the assembly and manipulation of nanoscale polymeric particles. Chem Sci (2012) 0.93
Poly(PS-b-DMA) micelles for reactive oxygen species triggered drug release. J Control Release (2012) 0.93
Challenges and breakthroughs in recent research on self-assembly. Sci Technol Adv Mater (2008) 0.90
A porous tissue engineering scaffold selectively degraded by cell-generated reactive oxygen species. Biomaterials (2014) 0.88
Recent trends in the tuning of polymersomes' membrane properties. Eur Phys J E Soft Matter (2011) 0.88
Physiologically relevant oxidative degradation of oligo(proline) cross-linked polymeric scaffolds. Biomacromolecules (2011) 0.87
Protein and enzyme gated supramolecular disassembly. J Am Chem Soc (2014) 0.86
ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial disease. Biomaterials (2014) 0.86
Critical evaluation of biodegradable polymers used in nanodrugs. Int J Nanomedicine (2013) 0.84
Exploiting oxidative microenvironments in the body as triggers for drug delivery systems. Antioxid Redox Signal (2014) 0.83
Loading of Silica Nanoparticles in Block Copolymer Vesicles during Polymerization-Induced Self-Assembly: Encapsulation Efficiency and Thermally Triggered Release. J Am Chem Soc (2015) 0.83
Curvature-driven molecular demixing in the budding and breakup of mixed component Worm-like Micelles. Soft Matter (2010) 0.83
Benzaldehyde-functionalized polymer vesicles. ACS Nano (2009) 0.82
Current progress in Reactive Oxygen Species (ROS)-Responsive materials for biomedical applications. Adv Healthc Mater (2013) 0.81
Fluorocoxib A loaded nanoparticles enable targeted visualization of cyclooxygenase-2 in inflammation and cancer. Biomaterials (2016) 0.80
Enzymatic- and temperature-sensitive controlled release of ultrasmall superparamagnetic iron oxides (USPIOs). J Nanobiotechnology (2011) 0.79
A new method of wound treatment: targeted therapy of skin wounds with reactive oxygen species-responsive nanoparticles containing SDF-1α. Int J Nanomedicine (2015) 0.78
Ultrasound and pH dually responsive polymer vesicles for anticancer drug delivery. Sci Rep (2013) 0.78
Tailoring Nanostructure Morphology for Enhanced Targeting of Dendritic Cells in Atherosclerosis. ACS Nano (2016) 0.78
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biol (2017) 0.77
Multifunctional nanoassemblies of block copolymers for future cancer therapy. Sci Technol Adv Mater (2010) 0.77
From stealthy polymersomes and filomicelles to "self" Peptide-nanoparticles for cancer therapy. Annu Rev Chem Biomol Eng (2014) 0.77
Phototocatalytic lithography of poly(propylene sulfide) block copolymers: toward high-throughput nanolithography for biomolecular arraying applications. Langmuir (2009) 0.77
End-group-functionalized poly(N,N-diethylacrylamide) via free-radical chain transfer polymerization: Influence of sulfur oxidation and cyclodextrin on self-organization and cloud points in water. Beilstein J Org Chem (2014) 0.77
Facile assembly and loading of theranostic polymersomes via multi-impingement flash nanoprecipitation. J Control Release (2017) 0.76
Biocompatible nanocarriers that respond to oxidative environments via interactions between chitosan and multiple metal ions. Int J Nanomedicine (2016) 0.75
Nanoparticle "switch-on" by tetrazine triggering. Chem Commun (Camb) (2016) 0.75
ROS-cleavable proline oligomer crosslinking of polycaprolactone for pro-angiogenic host response. J Mater Chem B Mater Biol Med (2014) 0.75
Polymeric micelles with dual thermal and reactive oxygen species (ROS)-responsiveness for inflammatory cancer cell delivery. J Nanobiotechnology (2017) 0.75
Particle-based technologies for osteoarthritis detection and therapy. Drug Deliv Transl Res (2016) 0.75
Self-Assembly of Amphiphilic Block Copolypeptoids - Micelles, Worms and Polymersomes. Sci Rep (2016) 0.75
Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain. Nat Commun (2017) 0.75
Immunotheranostic Polymersomes Modularly Assembled from Tetrablock and Diblock Copolymers with Oxidation-Responsive Fluorescence. Cell Mol Bioeng (2017) 0.75
Asymmetrical Polymer Vesicles for Drug delivery and Other Applications. Front Pharmacol (2017) 0.75
Synthetic/ECM-inspired hybrid platform for hollow microcarriers with ROS-triggered nanoporation hallmarks. Sci Rep (2017) 0.75
Programmable Nanoassemblies from Non-Assembling Homopolymers Using Ad Hoc Electrostatic Interactions. Angew Chem Int Ed Engl (2017) 0.75
Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol (2007) 3.75
Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol (2003) 3.71
Cell-wall recovery after irreversible deformation of wood. Nat Mater (2003) 3.09
Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J (2003) 2.85
Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog (2006) 2.65
JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia. Lancet Oncol (2007) 2.44
Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage. Nat Mater (2008) 2.12
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release (2006) 2.05
HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods (2002) 1.97
Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res (2004) 1.97
Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques. PLoS Pathog (2009) 1.92
Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol (2006) 1.85
Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. Biomaterials (2008) 1.82
Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel. Biomaterials (2008) 1.78
Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks. Biomaterials (2003) 1.77
Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci Transl Med (2011) 1.74
Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol (2003) 1.63
The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J (2010) 1.62
RIM-binding protein, a central part of the active zone, is essential for neurotransmitter release. Science (2011) 1.59
Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules (2002) 1.55
Controlled release nanoparticle-embedded coatings reduce the tissue reaction to neuroprostheses. J Control Release (2010) 1.54
Cell-responsive hydrogel for encapsulation of vascular cells. Biomaterials (2009) 1.50
Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions. Biomacromolecules (2007) 1.50
PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery. Biomacromolecules (2007) 1.49
Synthetic extracellular matrices for in situ tissue engineering. Biotechnol Bioeng (2004) 1.48
Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol Bioeng (2005) 1.47
Insulators, not Polycomb response elements, are required for long-range interactions between Polycomb targets in Drosophila melanogaster. Mol Cell Biol (2010) 1.47
The effect of matrix characteristics on fibroblast proliferation in 3D gels. Biomaterials (2010) 1.46
Reelin deficiency and displacement of mature neurons, but not neurogenesis, underlie the formation of granule cell dispersion in the epileptic hippocampus. J Neurosci (2006) 1.45
Engineering integrin signaling for promoting embryonic stem cell self-renewal in a precisely defined niche. Biomaterials (2009) 1.45
In vitro versus in vivo cellulose microfibrils from plant primary wall synthases: structural differences. J Biol Chem (2002) 1.44
Bovine primary chondrocyte culture in synthetic matrix metalloproteinase-sensitive poly(ethylene glycol)-based hydrogels as a scaffold for cartilage repair. Tissue Eng (2004) 1.43
RGD-grafted poly-L-lysine-graft-(polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion. Biotechnol Bioeng (2003) 1.40
Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc Natl Acad Sci U S A (2006) 1.39
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci U S A (2011) 1.39
Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci U S A (2013) 1.39
Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation. Vaccine (2010) 1.37
Engineering approaches to immunotherapy. Sci Transl Med (2012) 1.36
Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types. J Gen Virol (2008) 1.35
The significance of direct sunlight and polarized skylight in the ant's celestial system of navigation. Proc Natl Acad Sci U S A (2006) 1.35
Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering. Biomaterials (2007) 1.34
Poly(ethylene glycol) hydrogels formed by conjugate addition with controllable swelling, degradation, and release of pharmaceutically active proteins. J Control Release (2005) 1.30
Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science (2014) 1.27
Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70. J Virol (2004) 1.27
The effect of enzymatically degradable poly(ethylene glycol) hydrogels on smooth muscle cell phenotype. Biomaterials (2007) 1.26
In situ cell manipulation through enzymatic hydrogel photopatterning. Nat Mater (2013) 1.24
Engineering the regenerative microenvironment with biomaterials. Adv Healthc Mater (2012) 1.24
Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. Biomacromolecules (2006) 1.23
The effect of the linker on the hydrolysis rate of drug-linked ester bonds. J Control Release (2004) 1.21
Prediction of left ventricular remodeling and analysis of infarct resorption in patients with reperfused myocardial infarcts by using contrast-enhanced MR imaging. Radiology (2007) 1.21
The Mcp element mediates stable long-range chromosome-chromosome interactions in Drosophila. Mol Biol Cell (2006) 1.21
Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles. Eur J Pharm Sci (2006) 1.20
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose. Proc Natl Acad Sci U S A (2013) 1.20
The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials (2007) 1.18
Lymphatic drainage function and its immunological implications: from dendritic cell homing to vaccine design. Semin Immunol (2008) 1.17
Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: systematic optimisation of the preparative process and preliminary biological evaluation. Pharm Res (2009) 1.17
Homeostatic control of presynaptic neurotransmitter release. Annu Rev Physiol (2014) 1.16
Production of human papillomavirus type 16 virus-like particles in transgenic plants. J Virol (2003) 1.15
Human dimensions of forest disturbance by insects: an international synthesis. Environ Manage (2008) 1.14
Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells. Virology (2004) 1.13
Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part I: Development and physicochemical characteristics. Biomacromolecules (2005) 1.13
Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response. Biomaterials (2013) 1.13
Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice. PLoS One (2013) 1.12
Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice. J Virol (2003) 1.12
Checkers is solved. Science (2007) 1.10
Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate. PLoS One (2012) 1.08
Upregulation of inward rectifier K+ (Kir2) channels in dentate gyrus granule cells in temporal lobe epilepsy. J Physiol (2009) 1.08
Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release (2005) 1.07
Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes. Cancer Immunol Res (2014) 1.06
Neurite extension and in vitro myelination within three-dimensional modified fibrin matrices. J Neurobiol (2005) 1.06
Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1. J Virol (2006) 1.06
Mechanical properties of silk: interplay of deformation on macroscopic and molecular length scales. Phys Rev Lett (2008) 1.05
Characterization of the mechanical properties of qPlus sensors. Beilstein J Nanotechnol (2013) 1.05
Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin. Vaccine (2009) 1.05
Coordinated binding of Vps4 to ESCRT-III drives membrane neck constriction during MVB vesicle formation. J Cell Biol (2014) 1.05
Towards a fully-synthetic substitute of alginate: development of a new process using thermal gelation and chemical cross-linking. Biomaterials (2004) 1.05
The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies. Virology (2010) 1.04
DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvants. Genet Vaccines Ther (2008) 1.03
Long-term maintenance of mouse embryonic stem cell pluripotency by manipulating integrin signaling within 3D scaffolds without active Stat3. Biomaterials (2012) 1.03
A presynaptic ENaC channel drives homeostatic plasticity. Neuron (2013) 1.03
Increasing amino acid supply in pea embryos reveals specific interactions of N and C metabolism, and highlights the importance of mitochondrial metabolism. Plant J (2008) 1.02
Distribution and determinants of functioning and disability in aged adults--results from the German KORA-Age study. BMC Public Health (2013) 1.02
PEG-b-PPS diblock copolymer aggregates for hydrophobic drug solubilization and release: cyclosporin A as an example. Mol Pharm (2008) 1.02
Biomaterials science and high-throughput screening. Nat Biotechnol (2004) 1.01
Engineering antigens for in situ erythrocyte binding induces T-cell deletion. Proc Natl Acad Sci U S A (2012) 1.01
Synthesis and in vitro characterization of an ABC triblock copolymer for siRNA delivery. Bioconjug Chem (2007) 1.01
The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter. J Exp Med (2013) 1.01
Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials (2010) 1.01
Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor. Acta Biomater (2005) 1.00
A feeder-free, defined three-dimensional polyethylene glycol-based extracellular matrix niche for culture of human embryonic stem cells. Biomaterials (2013) 0.99
Determination of insecticidal Cry1Ab protein in soil collected in the final growing seasons of a nine-year field trial of Bt-maize MON810. Transgenic Res (2011) 0.99
Enhancer blocking and transvection at the Drosophila apterous locus. Genetics (2008) 0.99
TBX3 Directs Cell-Fate Decision toward Mesendoderm. Stem Cell Reports (2013) 0.98
Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaques. Hum Gene Ther (2012) 0.98